An overview of immune checkpoint inhibitors in breast cancer

• Egile Nagusiak: Federica Miglietta (Egilea), Maria Silvia Cona (Egilea), Maria Vittoria Dieci (Egilea), Valentina Guarneri (Egilea), Nicla La Verde (Egilea)
• Formatua: Liburua
• Argitaratua: Open Exploration Publishing Inc., 2020-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Although breast cancer is not traditionally considered an immunogenic type of tumor, the combination of immunotherapy and chemotherapy has recently emerged as a novel treatment option in triple-negative subtype in the advanced setting and other similar combinations of immune checkpoint inhibitors wi...